Skip to Main Content

Paper Details

Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil.
Mol Pharmacol
3
2021
5-Fluorodeoxyuridine, 5-fluorodeoxyuridine, 5-fluorouracil, Colorectal Cancer, Colorectal Cancer Cells, DNA, DNA repair enzyme, FU, FdU, Fluorouracil, Human, Human Uracil DNA Glycosylase, RTX, Raltitrexed, Uracil, advanced colorectal cancer, cancer, cancer cell, cancer cell lines, cancers, cell lines, colorectal, colorectal cell lines, colorectal lines, dT, deoxynucleoside, deoxyuridine, deoxyuridine triphosphate, doxycycline, doxycycline-inducible promoter, fluorouracil, hUNG, human, human uracil DNA glycosylase, p53, pyrimidine, raltitrexed, short, thymidylate synthase, thymine, thymine DNA glycosylase, uracil, uracil DNA glycosylase
Author NameAffiliation
Ben Ho ParkJohns Hopkins University School of Medicine, J.T.S.) Lieber Institute for Brain Development, Maryland (M.D.) and Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center
Ben Ho ParkJohns Hopkins University School of Medicine, J.T.S.) Lieber Institute for Brain Development, Maryland (M.D.) and Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center
  • 1 - 2

Datasets